LUCARELLI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 9.650
AS - Asia 3.462
EU - Europa 2.313
SA - Sud America 1.005
AF - Africa 108
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 16.547
Nazione #
US - Stati Uniti d'America 9.519
SG - Singapore 1.506
BR - Brasile 870
CN - Cina 801
HK - Hong Kong 518
SE - Svezia 455
RU - Federazione Russa 416
IT - Italia 391
VN - Vietnam 291
DE - Germania 289
GB - Regno Unito 180
FI - Finlandia 154
UA - Ucraina 135
FR - Francia 83
CA - Canada 80
IN - India 71
AR - Argentina 61
BE - Belgio 61
ID - Indonesia 48
BD - Bangladesh 44
CI - Costa d'Avorio 38
JP - Giappone 35
MX - Messico 35
ZA - Sudafrica 31
IQ - Iraq 26
EC - Ecuador 22
NL - Olanda 22
CO - Colombia 20
PL - Polonia 20
ES - Italia 19
IE - Irlanda 19
TR - Turchia 18
IR - Iran 13
AT - Austria 12
SA - Arabia Saudita 12
LT - Lituania 11
PK - Pakistan 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
MA - Marocco 9
EG - Egitto 8
KE - Kenya 7
CH - Svizzera 6
CL - Cile 6
NP - Nepal 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
KR - Corea 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
PH - Filippine 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BY - Bielorussia 3
EE - Estonia 3
HR - Croazia 3
IL - Israele 3
JM - Giamaica 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
Totale 16.539
Città #
Fairfield 1.261
Ashburn 1.045
Woodbridge 902
Chandler 795
Singapore 788
Houston 585
Seattle 520
Hong Kong 517
Cambridge 476
Wilmington 387
Nyköping 361
Ann Arbor 326
Beijing 290
Jacksonville 276
New York 202
Bari 158
Lawrence 156
Roxbury 155
Los Angeles 145
Munich 118
Dallas 116
Nanjing 113
Des Moines 99
Ho Chi Minh City 98
São Paulo 92
Princeton 77
Buffalo 61
Brussels 60
Hanoi 56
Boardman 55
Brooklyn 54
London 53
Santa Clara 53
Inglewood 52
San Diego 50
Dearborn 44
Abidjan 38
Chicago 36
Shenyang 36
The Dalles 36
Dong Ket 35
Jakarta 35
Hebei 34
Columbus 33
Redwood City 32
Helsinki 29
Turku 29
Montreal 28
Nanchang 27
Rio de Janeiro 25
Tokyo 25
Jiaxing 24
Paris 24
Tianjin 24
Brasília 23
Pune 23
San Jose 22
Toronto 22
Boston 21
Belo Horizonte 20
Campinas 20
Moscow 20
Changsha 19
Dublin 19
Rome 19
Frankfurt am Main 18
Stockholm 18
Augusta 17
Guangzhou 17
Warsaw 17
Council Bluffs 16
Phoenix 16
Curitiba 15
Mexico City 15
Bitonto 13
Denver 13
Falls Church 13
San Francisco 13
Johannesburg 12
Monmouth Junction 12
San Mateo 12
Atlanta 11
Chennai 11
Indianapolis 11
Orem 11
Porto Alegre 11
Amsterdam 10
Baghdad 10
Buenos Aires 10
Hefei 10
Manaus 10
Modugno 10
Nuremberg 10
Washington 10
Bogotá 9
Da Nang 9
Falkenstein 9
Haiphong 9
Manchester 9
Quito 9
Totale 11.800
Nome #
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 231
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 205
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 195
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 186
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 185
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 185
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 183
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 181
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 174
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 170
Isolation and characterization of cancer stem cells in renal cell carcinoma. 167
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 167
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 166
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 158
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 155
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 152
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 151
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 150
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 150
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 149
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 146
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 144
Allograft nephrectomy: what is the best surgical technique? 141
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 141
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 140
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 136
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 136
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 136
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 133
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 131
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 131
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 130
Penile prosthesis implant: when, what and how 129
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 128
Emerging urinary markers of renal injury in obstructive nephropathy. 126
"Deviceless" hand-assisted laparoscopic donor nephrectomy 120
null 119
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 119
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 119
Penile prosthesis: what should we do about complications? 118
Incidental prostatic cancer: repeat TURP or biopsy? 117
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 115
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 114
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 113
Emerging biomarkers in renal damage. 112
Editorial comment from Dr Lucarelli and Dr Ditonno to Impact of graft nephrectomy on outcomes of second kidney transplantation. 109
null 109
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 109
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 109
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 108
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 107
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 106
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 105
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 105
The emerging role of obesity, diet and lipid metabolism in prostate cancer 104
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 103
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 101
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 101
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 100
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 100
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 99
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma 99
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study 99
Testicular granulosa cell tumor of adult type: a new case and a review of the literature 98
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 98
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 98
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway 96
Incidentally discovered yellowish lesions in a renal graft from a deceased donor 95
Hem-O-Lok clip: A neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy 94
Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. 92
Obesity in kidney transplantation affects renal function but not graft and patient survival 92
Aligned Nanofiber Topographies Enhance the Differentiation of Adult Renal Stem Cells into Glomerular Podocytes 92
Transperitoneal deviceless hand-assisted laparoscopic living donor nephrectomy: an alternative technique for kidney recovery 91
Management of severe complications following penile surgery for erectile dysfunction and Peyronie disease: Three case reports 90
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 89
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas 88
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 87
Unusual solitary metastasis of the ciliary body in renal cell carcinoma 86
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 86
null 86
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 86
Complement Mediated Endothelial Cell (EC) Activation in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 86
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 85
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells 85
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review 85
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 83
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 83
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 81
Surgery for renal cell carcinoma in two European urologic clinics: to compare or compete? 81
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 80
Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury 80
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 79
CARCINOMA DELLA PROSTATA 76
US with contrast medium in the diagnosis of abdominal Castleman's disease 74
Extended Criteria Donor Kidney Transplantation: Comparative Outcome Analysis of Score 4 Graft Used as Single Transplant Versus Double Kidney Transplantation 74
null 74
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. 73
64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality? 73
Editorial comment. 71
null 71
Totale 11.665
Categoria #
all - tutte 76.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.159 0 0 0 0 0 69 223 211 110 212 215 119
2021/20221.109 71 95 18 35 42 103 42 64 71 118 164 286
2022/20231.909 290 230 131 174 189 259 25 242 283 16 46 24
2023/2024669 66 120 38 49 57 233 10 14 5 14 11 52
2024/20253.088 70 73 222 125 88 286 376 273 114 135 458 868
2025/20263.661 1.021 307 452 753 817 311 0 0 0 0 0 0
Totale 17.115